FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030439968> ?p ?o ?g. }

• W2030439968 endingPage "4186" @default.
• W2030439968 startingPage "4178" @default.
• W2030439968 abstract "Abstract Phosphatidylinositol 3′-kinase (PI3K) is a key player in cell-growth signaling in a number of lymphoid malignancies, but its role in diffuse large B-cell lymphoma (DLBCL) has not been fully elucidated. Therefore, we investigated the role of the PI3K/AKT pathway in a panel of 5 DLBCL cell lines and 100 clinical samples. Inhibition of PI3K by a specific inhibitor, LY294002, induced apoptosis in SUDHL4, SUDHL5, and SUDHL10 (LY-sensitive) cells, whereas SUDHL8 and OCI-LY19 (LY-resistant) cells were refractory to LY294002-induced apoptosis. AKT was phosphorylated in 5 of 5 DLBCL cell lines and inhibition of PI3K caused dephosphorylation/inactivation of constitutively active AKT, FOXO transcription factor, and GSK3 in LY-sensitive cell lines. In addition, there was a decrease in the expression level of inhibitory apoptotic protein, XIAP, in the DLBCL cell lines sensitive to LY294002 after treatment. However, no effect was observed in XIAP protein levels in the resistant DLBCL cell lines following LY294002 treatment. Finally, using immunohistochemistry, p-AKT was detected in 52% of DLBCL tumors tested. Furthermore, in univariate analysis, high p-AKT expression was associated with short survival. In multivariate analysis, this correlation was no longer significant. Altogether, these results suggest that the PI3K/AKT pathway may be a potential target for therapeutic intervention in DLBCL." @default.
• W2030439968 created "2016-06-24" @default.
• W2030439968 creator A5012192417 @default.
• W2030439968 creator A5015528853 @default.
• W2030439968 creator A5016350627 @default.
• W2030439968 creator A5018778229 @default.
• W2030439968 creator A5018975121 @default.
• W2030439968 creator A5023386424 @default.
• W2030439968 creator A5039935804 @default.
• W2030439968 creator A5047305971 @default.
• W2030439968 creator A5049791450 @default.
• W2030439968 creator A5055366985 @default.
• W2030439968 creator A5074062351 @default.
• W2030439968 creator A5080396108 @default.
• W2030439968 creator A5084116270 @default.
• W2030439968 date "2006-12-15" @default.
• W2030439968 modified "2023-10-10" @default.
• W2030439968 title "Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival" @default.
• W2030439968 cites W1496902741 @default.
• W2030439968 cites W1529396499 @default.
• W2030439968 cites W1550247880 @default.
• W2030439968 cites W1594020010 @default.
• W2030439968 cites W1604468403 @default.
• W2030439968 cites W1652264402 @default.
• W2030439968 cites W1877370095 @default.
• W2030439968 cites W1914067219 @default.
• W2030439968 cites W1970548320 @default.
• W2030439968 cites W1984098660 @default.
• W2030439968 cites W1986785675 @default.
• W2030439968 cites W1993134078 @default.
• W2030439968 cites W2000969116 @default.
• W2030439968 cites W2001838080 @default.
• W2030439968 cites W2006077720 @default.
• W2030439968 cites W2007530728 @default.
• W2030439968 cites W2029962300 @default.
• W2030439968 cites W2033801757 @default.
• W2030439968 cites W2043752262 @default.
• W2030439968 cites W2052369675 @default.
• W2030439968 cites W2056270776 @default.
• W2030439968 cites W2058138221 @default.
• W2030439968 cites W2058720172 @default.
• W2030439968 cites W2059221693 @default.
• W2030439968 cites W2059607489 @default.
• W2030439968 cites W2060083709 @default.
• W2030439968 cites W2063514430 @default.
• W2030439968 cites W2064109910 @default.
• W2030439968 cites W2065825082 @default.
• W2030439968 cites W2065919583 @default.
• W2030439968 cites W2081427260 @default.
• W2030439968 cites W2085060552 @default.
• W2030439968 cites W2087810003 @default.
• W2030439968 cites W2094079572 @default.
• W2030439968 cites W2095429914 @default.
• W2030439968 cites W2103413641 @default.
• W2030439968 cites W2108022289 @default.
• W2030439968 cites W2112893608 @default.
• W2030439968 cites W2113280225 @default.
• W2030439968 cites W2114311689 @default.
• W2030439968 cites W2117263216 @default.
• W2030439968 cites W2125698979 @default.
• W2030439968 cites W2129243136 @default.
• W2030439968 cites W2130158125 @default.
• W2030439968 cites W2130867126 @default.
• W2030439968 cites W2132411546 @default.
• W2030439968 cites W2152654745 @default.
• W2030439968 cites W2155231833 @default.
• W2030439968 cites W2157549025 @default.
• W2030439968 cites W2164032619 @default.
• W2030439968 cites W2169790726 @default.
• W2030439968 cites W2388163742 @default.
• W2030439968 cites W2608724752 @default.
• W2030439968 cites W4205736005 @default.
• W2030439968 cites W4293770031 @default.
• W2030439968 cites W69869516 @default.
• W2030439968 doi "https://doi.org/10.1182/blood-2006-04-016907" @default.
• W2030439968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16946303" @default.
• W2030439968 hasPublicationYear "2006" @default.
• W2030439968 type Work @default.
• W2030439968 sameAs 2030439968 @default.
• W2030439968 citedByCount "234" @default.
• W2030439968 countsByYear W20304399682012 @default.
• W2030439968 countsByYear W20304399682013 @default.
• W2030439968 countsByYear W20304399682014 @default.
• W2030439968 countsByYear W20304399682015 @default.
• W2030439968 countsByYear W20304399682016 @default.
• W2030439968 countsByYear W20304399682017 @default.
• W2030439968 countsByYear W20304399682018 @default.
• W2030439968 countsByYear W20304399682019 @default.
• W2030439968 countsByYear W20304399682020 @default.
• W2030439968 countsByYear W20304399682021 @default.
• W2030439968 countsByYear W20304399682022 @default.
• W2030439968 countsByYear W20304399682023 @default.
• W2030439968 crossrefType "journal-article" @default.
• W2030439968 hasAuthorship W2030439968A5012192417 @default.
• W2030439968 hasAuthorship W2030439968A5015528853 @default.
• W2030439968 hasAuthorship W2030439968A5016350627 @default.
• W2030439968 hasAuthorship W2030439968A5018778229 @default.
• W2030439968 hasAuthorship W2030439968A5018975121 @default.

• next